Glucose Activates Vagal Control of Hyperglycemia and Inflammation in Fasted Mice.

Journal Article

Sepsis is a leading cause of death in hospitalized patients. Many experimental treatments may have failed in clinical trials for sepsis, in part, because they focused on immune responses of healthy animals that did not mimic the metabolic settings of septic patients. Epidemiological studies show an association between metabolic and immune alterations and over 1/3 of septic patients are diabetic, but the mechanism linking these systems is unknown. Here, we report that metabolic fasting increased systemic inflammation and worsened survival in experimental sepsis. Feeding and administration of glucose in fasted mice activated the vagal tone without affecting blood pressure. Vagal stimulation attenuated hyperglycemia and serum TNF levels in sham but only hyperglycemia in splenectomized mice. Vagal stimulation induced the production of dopamine from the adrenal glands. Experimental diabetes increased hyperglycemia and systemic inflammation in experimental sepsis. Fenoldopam, a specific dopaminergic type-1 agonist, attenuated hyperglycemia and systemic inflammation in diabetic endotoxemic mice. These results indicate that glucose activates vagal control of hyperglycemia and inflammation in fasted septic mice via dopamine.

Full Text

Duke Authors

Cited Authors

  • Joseph, B; Shimojo, G; Li, Z; Thompson-Bonilla, MDR; Shah, R; Kanashiro, A; Salgado, HC; Ulloa, L

Published Date

  • January 30, 2019

Published In

Volume / Issue

  • 9 / 1

Start / End Page

  • 1012 -

PubMed ID

  • 30700738

Pubmed Central ID

  • 30700738

Electronic International Standard Serial Number (EISSN)

  • 2045-2322

Digital Object Identifier (DOI)

  • 10.1038/s41598-018-36298-z


  • eng

Conference Location

  • England